AU Stock MarketDetailed Quotes

HPC The Hydration Pharmaceuticals Co Ltd

Watchlist
  • 0.018
  • 0.0000.00%
20min DelayNot Open Dec 10 11:10 AET
5.49MMarket Cap-0.31P/E (Static)

The Hydration Pharmaceuticals Co Ltd Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 30, 2023
(FY)Dec 30, 2022
(FY)Dec 30, 2021
Total revenue
10.18%14.74M
58.26%13.38M
8.45M
Operating revenue
10.18%14.74M
58.26%13.38M
--8.45M
Cost of revenue
5.43%6.82M
40.59%6.47M
4.6M
Gross profit
14.64%7.91M
79.39%6.9M
3.85M
Operating expense
-14.83%19.28M
59.52%22.63M
14.19M
Selling and administrative expenses
-14.83%19.28M
70.57%22.63M
--13.27M
-Selling and marketing expense
-25.91%10.05M
94.30%13.56M
--6.98M
-General and administrative expense
1.73%9.23M
44.24%9.07M
--6.29M
Depreciation amortization depletion
----
----
--4.6K
-Depreciation and amortization
----
----
--4.6K
Other operating expenses
----
----
--914.97K
Operating profit
27.76%-11.36M
-52.12%-15.73M
-10.34M
Net non-operating interest income (expenses)
-603.88%-943.64K
96.61%-134.06K
-3.95M
Non-operating interest income
----
-94.27%7.3497
--128.2916
Non-operating interest expense
603.84%943.64K
-96.61%134.07K
--3.95M
Other net income (expenses)
51.76%414.5K
-85.96%273.14K
1.95M
Other non-operating income (expenses)
51.76%414.5K
-85.96%273.14K
--1.95M
Income before tax
23.73%-11.89M
-26.26%-15.59M
-12.35M
Income tax
0
0
0
Earnings from equity interest net of tax
Net income
23.73%-11.89M
-26.26%-15.59M
-12.35M
Net income continuous operations
23.73%-11.89M
-26.26%-15.59M
---12.35M
Noncontrolling interests
Net income attributable to the company
23.73%-11.89M
-26.26%-15.59M
-12.35M
Preferred stock dividends
Other under preferred stock dividend
Net income attributable to common stockholders
23.73%-11.89M
-26.26%-15.59M
-12.35M
Diluted earnings per share
36.81%-0.0587
42.10%-0.0929
-0.1605
Basic earnings per share
36.81%-0.0587
42.10%-0.0929
-0.1605
Dividend per share
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
(FY)Dec 30, 2023(FY)Dec 30, 2022(FY)Dec 30, 2021
Total revenue 10.18%14.74M58.26%13.38M8.45M
Operating revenue 10.18%14.74M58.26%13.38M--8.45M
Cost of revenue 5.43%6.82M40.59%6.47M4.6M
Gross profit 14.64%7.91M79.39%6.9M3.85M
Operating expense -14.83%19.28M59.52%22.63M14.19M
Selling and administrative expenses -14.83%19.28M70.57%22.63M--13.27M
-Selling and marketing expense -25.91%10.05M94.30%13.56M--6.98M
-General and administrative expense 1.73%9.23M44.24%9.07M--6.29M
Depreciation amortization depletion ----------4.6K
-Depreciation and amortization ----------4.6K
Other operating expenses ----------914.97K
Operating profit 27.76%-11.36M-52.12%-15.73M-10.34M
Net non-operating interest income (expenses) -603.88%-943.64K96.61%-134.06K-3.95M
Non-operating interest income -----94.27%7.3497--128.2916
Non-operating interest expense 603.84%943.64K-96.61%134.07K--3.95M
Other net income (expenses) 51.76%414.5K-85.96%273.14K1.95M
Other non-operating income (expenses) 51.76%414.5K-85.96%273.14K--1.95M
Income before tax 23.73%-11.89M-26.26%-15.59M-12.35M
Income tax 000
Earnings from equity interest net of tax
Net income 23.73%-11.89M-26.26%-15.59M-12.35M
Net income continuous operations 23.73%-11.89M-26.26%-15.59M---12.35M
Noncontrolling interests
Net income attributable to the company 23.73%-11.89M-26.26%-15.59M-12.35M
Preferred stock dividends
Other under preferred stock dividend
Net income attributable to common stockholders 23.73%-11.89M-26.26%-15.59M-12.35M
Diluted earnings per share 36.81%-0.058742.10%-0.0929-0.1605
Basic earnings per share 36.81%-0.058742.10%-0.0929-0.1605
Dividend per share
Accounting Standards US-GAAPUS-GAAPUS-GAAP
Heat List
AU
Overall
Symbol
Price
% Chg

No Data